Services

Market Access & Pricing

We combine payer and KOL interviews, analogue benchmarking, pricing models, and regional contracting design to quantify value drivers and shape evidence generation. Our outputs focus on crafting payer messaging, tailored pricing recommendations, channel and coverage strategies, and country launch roadmaps that reduce reimbursement risk, maximize net price realization, and inform commercial sequencing.​​​

Case Studies

Value Proposition and Franchise Optimization

 

Tailoring of a value proposition and access strategy for a new oncology therapy in Newly Diagnosed Multiple Myeloma (NDMM).​

Insights

Challenge: Client needed to assess the opportunity in NDMM for a new therapy and determine the optimal   access strategy that will maximize franchise value across indications.

Approach: Scimitar completed a comparative assessment of competitors against various factors and payer / KOL interviews to quantifying perceptions / value. A targeted patient message assessment and segment was conducted to determine optimal communication and segments to tackle.

Impact: Delivered price potential assessments and cross‑functional implications that support re-shaping of payer engagement and launch sequencing.

Global Market Access Strategy

 

Development of country‑level market access roadmaps using pricing/access analogue assessment for a cardiology rare disease asset.

Insights

Challenge: A late-stage clinical biopharma company needed support to develop a global market access strategy for its cardiology rare disease asset. They wanted to conduct a pricing and access analogue assessment to determine an appropriate access and pricing strategy.

Approach: Scimitar reviewed pre-existing research across opportunity assessment, pricing, and brand strategic plans to determine criteria for assessment. We leverage the content to collaborate with internal stakeholders to create country-specific launch plans and access roadmaps.

Impact: Generated deliverables contributed to key actions and timing to execute reimbursement strategy and launch planning efforts.